GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Research & Development

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Research & Development : ¥89 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Luoxin Pharmaceuticals Group Stock Co's Research & Development for the three months ended in Mar. 2024 was ¥15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥89 Mil.


Luoxin Pharmaceuticals Group Stock Co Research & Development Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Research & Development Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 420.00 361.27 320.95 204.73 112.27

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.89 22.99 29.29 21.10 15.35

Luoxin Pharmaceuticals Group Stock Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luoxin Pharmaceuticals Group Stock Co  (SZSE:002793) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Luoxin Pharmaceuticals Group Stock Co Research & Development Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Traded in Other Exchanges
N/A
Address
85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Executives
Ye Bang Mi Supervisors
Fang Xiu Bao Directors, executives
Zhu Fu Lin Directors, executives
Chen Li Supervisors
Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines